Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVAX | Common Stock | Options Exercise | +2.1K | +76.09% | 4.86K | Dec 14, 2021 | Direct | F1 | ||
transaction | NVAX | Common Stock | Tax liability | -$171K | -1.02K | -20.88% | $168.43* | 3.85K | Dec 14, 2021 | Direct | |
holding | NVAX | Common Stock | 1.75K | Dec 14, 2021 | By spouse | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVAX | Restricted Stock Units | Options Exercise | $0 | -2.1K | -33.33% | $0.00 | 4.2K | Dec 14, 2021 | Common Stock | 2.1K | Direct | F1, F3 |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
F2 | The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. |
F3 | The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the December 14, 2020 grant date, in each case subject to continued employment through such vesting date. |